Argomento di ricerca

Heart Health

Cardiovascular disease prevention, blood pressure, cholesterol, and heart function

617 articoli

Diet Alone Can Cut LDL by 30% and Rival Blood Pressure Drugs
Heart Health

Diet Alone Can Cut LDL by 30% and Rival Blood Pressure Drugs

Simon Hill's cardiovascular masterclass covers the Portfolio Diet, plaque regression, ApoB testing, and the sodium-potassium ratio with top experts.

Podcast
22 mag 2026 0
High Fitness in Youth Protects the Heart Despite Slight Atrial Fibrillation Risk
Heart Health

High Fitness in Youth Protects the Heart Despite Slight Atrial Fibrillation Risk

A million-man study finds that adolescent cardiorespiratory fitness delivers net cardiovascular benefits that far outweigh any AF risk.

Articolo scientifico
22 mag 2026 0
Heart Enzyme PYGM Shields Against Heart Attack by Boosting Energy and Autophagy
Heart Health

Heart Enzyme PYGM Shields Against Heart Attack by Boosting Energy and Autophagy

A muscle enzyme that declines in heart attack patients may hold the key to preserving cardiac function after MI.

Articolo scientifico
21 mag 2026 0
Barth Syndrome Management Gets a Boost With Targeted Elamipretide Therapy
Heart Health

Barth Syndrome Management Gets a Boost With Targeted Elamipretide Therapy

A comprehensive GeneReviews update on Barth syndrome outlines diagnosis, new targeted therapy, and surveillance strategies for this rare X-linked disorder.

Articolo scientifico
20 mag 2026 0
Elamipretide Wins First FDA Approval for Barth Syndrome Via Mitochondrial Repair
Heart Health

Elamipretide Wins First FDA Approval for Barth Syndrome Via Mitochondrial Repair

The first disease-specific treatment for Barth syndrome gains FDA accelerated approval, targeting mitochondrial dysfunction to restore muscle strength.

Articolo scientifico
20 mag 2026 0
Mitochondrial Protein GTPBP3 Found Essential for Blood Vessel Growth and Ischemia Recovery
Heart Health

Mitochondrial Protein GTPBP3 Found Essential for Blood Vessel Growth and Ischemia Recovery

Deleting GTPBP3 in endothelial cells blocks angiogenesis via mtROS overload — and a mitochondria-targeted antioxidant reverses the damage.

Articolo scientifico
20 mag 2026 0
Two-Year Plant-Based Supplement Trial for Inflammaging in Overweight Seniors Terminated Early
Heart Health

Two-Year Plant-Based Supplement Trial for Inflammaging in Overweight Seniors Terminated Early

A 2-year clinical trial testing Juice Plus+ products against low-grade inflammation and biological aging markers in overweight seniors was terminated before completion.

Sperimentazione clinica
20 mag 2026 0
Inflammaging Biomarkers Causally Reshape Retinal Vessels and Predict Cardiovascular Fate
Heart Health

Inflammaging Biomarkers Causally Reshape Retinal Vessels and Predict Cardiovascular Fate

Mendelian randomization links circulating inflammatory proteins to retinal microvascular changes, heart disease risk, and lifespan — establishing causal direction.

Articolo scientifico
20 mag 2026 0
How Your Heart Ages and What Science Can Do to Slow It Down
Heart Health

How Your Heart Ages and What Science Can Do to Slow It Down

A 2025 review maps the molecular mechanisms driving cardiovascular aging—from inflammaging to ECM remodeling—and outlines emerging therapies.

Articolo scientifico
20 mag 2026 0
NR Supplementation Tested as Cardiac Rescue in Systolic Heart Failure Patients
Heart Health

NR Supplementation Tested as Cardiac Rescue in Systolic Heart Failure Patients

A Phase 1/2 trial tests whether nicotinamide riboside can restore NAD+ balance and improve heart function in systolic HF patients.

Sperimentazione clinica
20 mag 2026 0
Social Adversity Quadruples Mortality Risk in HIV Patients With Heart Failure
Heart Health

Social Adversity Quadruples Mortality Risk in HIV Patients With Heart Failure

A NYC cohort study finds social adversity dramatically raises mortality and rehospitalization in people living with HIV and heart failure.

Articolo scientifico
20 mag 2026 0
Evolocumab Cuts Heart Attack Risk 50% in PCI Patients Without Prior MI
Heart Health

Evolocumab Cuts Heart Attack Risk 50% in PCI Patients Without Prior MI

A major trial shows evolocumab dramatically reduces cardiovascular events in stent patients who've never had a heart attack.

Articolo scientifico
20 mag 2026 0
PrecedentePagina 9 di 52Avanti